Group items matching

in title, tags, annotations or url

Cervical screening is one of the best ways to protect women from cervical cancer, which claims nearly two lives daily in England, according to NHS England. Therefore, all women and those with a cervix between the ages of 25 and 64 are encouraged to attend cervical screening when invited. Sadly, 3 in 10 of those eligible for cervical screening do not take up the potentially life-saving offer, as revealed by the NHS Cervical Screening Programme, England 2022-2023 annual report. Pharmacist Thorrun Govind, also a Healthcare Lawyer (Brabners LLP), underscores the significant role pharmacists and pharmacy teams can play in promoting cervical cancer screening. The former Chair of the Royal Pharmaceutical Society (RPS) in England told Pharmacy Business: "Pharmacists and pharmacy teams are a trusted part of the local community. They therefore have a key part in promoting cervical cancer screening."

The Leverhulme Trade Charities Trust (LTCT) has announced the launch of a new scheme to support pharmacists and their families during the back-to-school period. Opening at 9 am on Tuesday, June 18, 2024, the 'School Essentials Grant' is designed to alleviate financial pressure for people working in community pharmacies with young children during one of the most costly times of the year. The scheme will see the charity provide up to £100,000 of support to pharmacists in need of financial aid. Eligible families can apply online to receive £150 per school-age child, up to a maximum of three children per household. This grant can be used for essential expenses such as new school uniforms, stationery, or travel passes. The application window will remain open until September 1 or until the fund has been depleted. Hence, families are encouraged to apply as soon as they can.

OMNISCAN invented by Dr. Steven Quay is the world's first non-ionic MRI contrast agent. It's the world's first non-ionic MRI contrast agent. MRI contrasts, such as Omni scan may be an appropriate choice for eligible patients and procedures based on its clinical profile and a long tradition of patient and clinician experience.